Delivery Order SPE2D020D0014-SPE2D325F334X
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Pfizer Inc., a global pharmaceutical corporation headquartered in New York. The $443,481.61 delivery order contract is for firm fixed-price medical supplies and pharmaceuticals, including controlled substances, injectable medications, and critical medical products. The contract has no small business set-aside designation, reflecting Pfizer's status as a large, established...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HETASTARCH 6%-0.9% NACL BAG 500ML, a medical supply product, with a ceiling value of $1,386.24 and a performance period through February 12, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition....
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at approximately $1,225 to Amerisourcebergen Drug Corporation for HETASTARCH IN LACTATE. The prime contractor will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements by August 18, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports the Department of Defense by...
- Pfizer Inc. is providing $819,005.63 worth of other medical products to the Defense Logistics Agency Troop Support Medical under an August 15, 2022 firm fixed-price delivery order. No set-aside designation was used for this award. Performance will take place in New York, NY and is required to be completed by August 31, 2023. As the prime contractor, Pfizer will deliver the unspecified medical products directly without involvement of major subcontractors. Pfizer holds additional contracts with...
- The U.S. Department of Defense, through its Medical Supply Chain component, awarded a $2,397.00 firm fixed-price delivery order to Pfizer Inc. on August 20, 2025, for the supply of Quelicin 200 mg/10 ml vials. This single delivery order, which must be completed by August 21, 2025, represents a continuation of Pfizer's established role as a critical supplier of injectable medications and pharmaceutical products to federal healthcare agencies. The contract does not utilize a small business...
- The Defense Logistics Agency Troop Support Medical awarded a $1,225 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for 4562080903 HETASTARCH IN LACTATE. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested medical product to the agency's location in Conshohocken, Pennsylvania by September 7, 2023. The funding comes through the Defense Logistics Agency Troop Support Medical contract vehicle. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a $253,480 delivery order to Pfizer Inc. for conjugated estrogens injection solution. The order was placed against an existing contract vehicle to supply 2 million milliliters of the product. Pfizer will deliver the medication from its New York manufacturing facility to an unspecified customer by August 3, 2023. The firm fixed price order was competitively awarded without any set aside provisions. As a major provider of pharmaceuticals...
- <p>The Defense Logistics Agency Troop Support Medical awarded a delivery order against an undisclosed contract vehicle to Pfizer Inc. for $597.30. Pfizer will provide 4561814992 fosphenytoin sodium at 50mg per ml in 10ml vials to the agency from its New York City location between August 15-18, 2023. The firm fixed price order is for the specified pharmaceutical to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated.</p>
- The U.S. Department of Defense, through its Medical Supply Chain component of the Defense Logistics Agency Troop Support, awarded a delivery order to Pfizer Inc. on August 20, 2025, for the supply of Cleocin Phos 150 mg/mL vials in 6 mL quantities. This firm fixed-price delivery order, valued at $1,431.20, represents a critical pharmaceutical procurement to support military medical operations and healthcare programs. The contract carries an ultimate completion date of August 21, 2025, and will...
- This is a $380,405.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract does not have a set-aside designation. Pfizer, a global pharmaceutical company, is providing a variety of pharmaceutical products and supplies to support healthcare initiatives across multiple federal agencies. This contract is part of Pfizer's larger Indefinite Delivery Vehicle (IDV) contracts, including a $7.31 billion Federal Supply...
- SPE2D020D0014Indefinite Delivery Contract
- SPE2D020D0014-SPE2D325F334XDelivery Order
On August 20, 2025, the Medical Supply Chain, a component of the Defense Logistics Agency, awarded a delivery order valued at $3,808.20 to Pfizer Inc. for the supply of Hetastarch 6%-0.9% sodium chloride solution in 500 mL bags. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and no small business set-aside designation was utilized. The contract will be performed in New York, New York, where Pfizer maintains significant operations as a leading pharmaceutical supplier to federal government agencies. Pfizer, a global pharmaceutical corporation headquartered in New York, holds established status as a prime federal contractor specializing in injectable medications and critical medical supplies for defense and civilian health programs. This delivery order represents one of numerous contracts the company fulfills through the Medical Supply Chain, an established prime vendor program serving the Department of Defense and other federal healthcare organizations. Hetastarch is a plasma volume expander used in medical settings for fluid resuscitation, reflecting Pfizer's ongoing role in supplying essential injectable pharmaceuticals and medical solutions across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/20/25 |